The prescription heart medication Multaq (dronedarone), manufactured by Sanofi-Aventis, was approved by the Food and Drug Administration (“FDA”) on July 1, 2009. Multaq is indicated for treatment of abnormal heart rhythm in patients who have had an abnormal heart rhythm (atrial fibrillation or atrial flutter) during the past 6 months.
On January 14, 2011, the FDA announced that new warnings will be added to the Multaq label advising doctors and patients that Multaq has been associated with severe liver damage, in some cases requiring a liver transplant.
Symptoms That May Indicate Liver Damage
Signs of liver damage include, but are not limited to:
- Yellowing of the skin or eyes
- Loss of appetite
- Significant itching
What You Can Do If You Or a Loved One Has Been Injured by Multaq
If you or someone you know has taken Multaq prior to January 14, 2011 and experienced any of the side effects associated with this drug, it is important to seek medical attention as soon as possible. Anyone suffering from the side effects of liver damage resulting from Multaq use may have a right to seek compensation for their losses. Our Multaq attorneys are reviewing new cases of those injured and are ready and able to assist. Anyone injured by Multaq may contact us directly at 1-800-738-0449, or contact us through our website at www.lawyernc.com.
